ArticlePain2026
Hydrogen-rich water alleviates neuropathic pain through the modulation of bile acid/Takeda G-protein-coupled receptor 5-mediated autophagy.
Article in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioactive compounds for neuroinflammation and neuropathic pain management: molecular and cellular mechanisms.Inflammopharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
abstractNeuropathic pain is a chronic, intractable condition characterized by a complex pathogenesis. Hydrogen-rich water (HRW) has been reported to have possible analgesic properties, but the underlying mechanisms remain unclear. To investigate the effects of HRW, we utilized an L4 spinal nerve ligation (SNL) model in both male and female mice. Pain behaviors were quantitatively assessed using paw withdrawal threshold, paw withdrawal latency, and acetone response tests. Fecal microbiota composition was analyzed through 16S rRNA sequencing, and serum bile acids were assessed by liquid chromatography-mass spectrometry. The expression of bile acid membrane receptor Takeda G-protein-coupled receptor 5 (TGR5) and autophagy markers were evaluated in spinal cord, dorsal root ganglia, and colon through biochemistry experiments. Autophagic structures were examined using transmission electron microscopy. We further validated the roles of TGR5 and autophagy in neuropathic pain through experiments using rapamycin treatment and TGR5 knockout mouse models. The effect of HRW on intestinal barrier function was also tested. We found that HRW effectively ameliorated behavioral deficits associated with SNL-induced neuropathic pain. In addition, HRW facilitated the repair of the damaged gut barrier, restored the disrupted intestinal microbiota, and modulated bile acid metabolism in SNL mice. Interventions with hyodeoxycholic acid and deoxycholic acid produced analgesic effects similar to those of HRW. Takeda G-protein-coupled receptor 5 knockdown reversed the therapeutic effects of HRW and rapamycin. Mechanistically, HRW alleviates neuropathic pain by modulating bile acid metabolites linked to intestinal microbiota and directly or indirectly activating TGR5 in the spinal cord, dorsal root ganglia, and colon, thereby promoting autophagy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.